Atlas Trials

Shanghai De Novo Pharmatech Co., Ltd.

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Shanghai De Novo Pharmatech Co., Ltd.

RecordFirmDate
A Study to Evaluate the Safety, Tolerability of DN1508052-01 in Advanced Solid Tumors (NCT03934359)Shanghai De Novo Pharmatech Co., Ltd.2019-09-18

Track Shanghai De Novo Pharmatech Co., Ltd. automatically

Every clearance here is in the API, with alerts when new ones post.